A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates-Reference-Cited by-同舟云学术

A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates

Published:2011-12 Issue:12 Volume:216 Page:1239-1247
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Fernández-Marrero Yuniel,Roque-Navarro Lourdes,Hernández Tays,Dorvignit Denise,Molina-Pérez Marively,González Addys,Sosa Katya,López-Requena Alejandro,Pérez Rolando,Mateo de Acosta Cristina

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference66 articles.

1. Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies: roles of anoikis;Aixinjueluo;J. Biol. Chem.,2005

2. T cell-independent B cell response to self-monosialogangliosides: primary response monoclonal antibodies;Alfonso;Hybridoma,1995

3. Humanization of antibodies;Almagro;Front. Biosci.,2008

4. Glycolipid depletion using a ceramide analogue (PDMP) alters growth, adhesion, and membrane lipid organization in human A431 cells;Barbour;J. Cell. Physiol.,1992

5. Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells;Bardor;J. Biol. Chem.,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive sphingolipids as emerging targets for signal transduction in cancer development;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Chimeric antigen receptor T cells targeting the GM3(Neu5Gc) ganglioside;Frontiers in Immunology;2024-02-02

3. Detection of N-glycolyl-neuraminic acid-containing glycolipids in human skin;Frontiers in Immunology;2023-11-29

4. N-glycolylneuraminic acid as a carbohydrate cancer biomarker;Translational Oncology;2023-05

5. SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the N-glycolyl GM3-specific anti-tumor antibody 14F7;Frontiers in Immunology;2022-11-09